Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ylpm1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YLPM1 mRNA | CTD | PMID:36331819 | Ylpm1 | Rat | 1,2-dimethylhydrazine | affects expression | ISO | Ylpm1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine affects the expression of YLPM1 mRNA | CTD | PMID:22206623 | Ylpm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of YLPM1 mRNA | CTD | PMID:19770486 | Ylpm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of YLPM1 mRNA | CTD | PMID:33387578 | Ylpm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of YLPM1 mRNA | CTD | PMID:34747641 | Ylpm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of YLPM1 mRNA | CTD | PMID:21570461 | Ylpm1 | Rat | 4,4'-sulfonyldiphenol | affects expression | ISO | YLPM1 (Homo sapiens) | 6480464 | bisphenol S affects the expression of YLPM1 protein | CTD | PMID:31945527 | Ylpm1 | Rat | all-trans-retinoic acid | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of YLPM1 mRNA | CTD | PMID:33167477 | Ylpm1 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of YLPM1 mRNA | CTD | PMID:30779732 | Ylpm1 | Rat | Aroclor 1254 | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of YLPM1 mRNA | CTD | PMID:23650126 | Ylpm1 | Rat | arsane | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | arsenic atom | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | arsenite(3-) | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to YLPM1 mRNA] | CTD | PMID:32406909 | Ylpm1 | Rat | arsenous acid | increases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of YLPM1 mRNA | CTD | PMID:20458559 | Ylpm1 | Rat | benzo[a]pyrene | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of YLPM1 mRNA | CTD | PMID:22228805 | Ylpm1 | Rat | benzo[a]pyrene | increases methylation | ISO | Ylpm1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of YLPM1 intron | CTD | PMID:27901495 | Ylpm1 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YLPM1 mRNA | CTD | PMID:19150397 | Ylpm1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of YLPM1 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Ylpm1 | Rat | bisphenol A | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of YLPM1 mRNA | CTD | PMID:33221593 | Ylpm1 | Rat | butanal | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of YLPM1 mRNA | CTD | PMID:26079696 | Ylpm1 | Rat | Butylbenzyl phthalate | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of YLPM1 mRNA | CTD | PMID:28392331 | Ylpm1 | Rat | cadmium dichloride | increases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of YLPM1 mRNA | CTD | PMID:38382870 | Ylpm1 | Rat | caffeine | decreases phosphorylation | ISO | YLPM1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of YLPM1 protein | CTD | PMID:35688186 | Ylpm1 | Rat | chlorpyrifos | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of YLPM1 mRNA | CTD | PMID:37019170 | Ylpm1 | Rat | choline | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Ylpm1 | Rat | cisplatin | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of YLPM1 mRNA | CTD | PMID:27594783 | Ylpm1 | Rat | clobetasol | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of YLPM1 mRNA | CTD | PMID:27462272 | Ylpm1 | Rat | cobalt dichloride | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of YLPM1 mRNA | CTD | PMID:19376846 | Ylpm1 | Rat | cyclosporin A | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of YLPM1 mRNA | CTD | PMID:19770486 | Ylpm1 | Rat | diarsenic trioxide | increases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of YLPM1 mRNA | CTD | PMID:20458559 | Ylpm1 | Rat | Dibutyl phosphate | affects expression | ISO | YLPM1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of YLPM1 mRNA | CTD | PMID:37042841 | Ylpm1 | Rat | dicrotophos | increases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of YLPM1 mRNA | CTD | PMID:28302478 | Ylpm1 | Rat | dorsomorphin | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ylpm1 | Rat | doxorubicin | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of YLPM1 mRNA | CTD | PMID:29803840 | Ylpm1 | Rat | elemental selenium | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of YLPM1 mRNA | CTD | PMID:19244175 | Ylpm1 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of YLPM1 mRNA | CTD | PMID:29391264 | Ylpm1 | Rat | enzyme inhibitor | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Ylpm1 | Rat | ethanol | affects splicing | ISO | Ylpm1 (Mus musculus) | 6480464 | Ethanol affects the splicing of YLPM1 mRNA | CTD | PMID:30319688 | Ylpm1 | Rat | folic acid | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Ylpm1 | Rat | folic acid | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of YLPM1 mRNA | CTD | PMID:25629700 | Ylpm1 | Rat | FR900359 | affects phosphorylation | ISO | YLPM1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of YLPM1 protein | CTD | PMID:37730182 | Ylpm1 | Rat | inulin | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of YLPM1 mRNA | CTD | PMID:36331819 | Ylpm1 | Rat | ivermectin | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of YLPM1 protein | CTD | PMID:32959892 | Ylpm1 | Rat | L-methionine | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Ylpm1 | Rat | manganese atom | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | manganese(0) | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | manganese(II) chloride | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | mercury dichloride | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased expression of YLPM1 mRNA | CTD | PMID:27188386 | Ylpm1 | Rat | miconazole | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Miconazole results in decreased expression of YLPM1 mRNA | CTD | PMID:27462272 | Ylpm1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of YLPM1 mRNA | CTD | PMID:33387578 | Ylpm1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ylpm1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YLPM1 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Ylpm1 | Rat | phenobarbital | affects expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of YLPM1 mRNA | CTD | PMID:23091169 | Ylpm1 | Rat | phenylmercury acetate | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of YLPM1 mRNA | CTD | PMID:26272509 | Ylpm1 | Rat | phenylmercury acetate | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ylpm1 | Rat | pirinixic acid | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of YLPM1 mRNA | CTD | PMID:18301758|PMID:23811191 | Ylpm1 | Rat | potassium dichromate | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of YLPM1 mRNA | CTD | PMID:23608068 | Ylpm1 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of YLPM1 mRNA | CTD | PMID:19162173 | Ylpm1 | Rat | SB 431542 | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of YLPM1 more ... | CTD | PMID:27188386|PMID:37664457 | Ylpm1 | Rat | selenium atom | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of YLPM1 mRNA | CTD | PMID:19244175 | Ylpm1 | Rat | sodium arsenate | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | sodium arsenate results in decreased expression of YLPM1 protein | CTD | PMID:38348393 | Ylpm1 | Rat | sodium arsenite | multiple interactions | ISO | YLPM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Ylpm1 | Rat | sodium fluoride | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of YLPM1 protein | CTD | PMID:28918527 | Ylpm1 | Rat | thapsigargin | increases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Thapsigargin results in increased expression of YLPM1 protein | CTD | PMID:24648495 | Ylpm1 | Rat | titanium dioxide | increases methylation | ISO | Ylpm1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of YLPM1 promoter | CTD | PMID:35295148 | Ylpm1 | Rat | titanium dioxide | decreases methylation | ISO | YLPM1 (Homo sapiens) | 6480464 | titanium dioxide results in decreased methylation of YLPM1 gene | CTD | PMID:34973136 | Ylpm1 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of YLPM1 mRNA | CTD | PMID:33387578 | Ylpm1 | Rat | triphenyl phosphate | affects expression | ISO | YLPM1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of YLPM1 mRNA | CTD | PMID:37042841 | Ylpm1 | Rat | troglitazone | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of YLPM1 mRNA | CTD | PMID:28973697 | Ylpm1 | Rat | tungsten | decreases expression | ISO | Ylpm1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of YLPM1 mRNA | CTD | PMID:30912803 | Ylpm1 | Rat | urethane | increases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Urethane results in increased expression of YLPM1 mRNA | CTD | PMID:28818685 | Ylpm1 | Rat | valproic acid | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of YLPM1 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251 | Ylpm1 | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of YLPM1 mRNA | CTD | PMID:29427782 | Ylpm1 | Rat | vitamin E | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of YLPM1 mRNA | CTD | PMID:19244175 | Ylpm1 | Rat | vorinostat | decreases expression | ISO | YLPM1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of YLPM1 mRNA | CTD | PMID:27188386 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















